Reproducibility of Deceased Donor Kidney Procurement Biopsies.

allografts atrophy biopsy cohort studies confidence intervals deceased donor kidney humans kidney kidney biopsy kidney transplantation probability procurement reproducibility of results sclerosis tissue and organ procurement tissue donors transplant pathology vascular diseases

Journal

Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570

Informations de publication

Date de publication:
07 02 2020
Historique:
received: 06 08 2019
accepted: 05 12 2019
pubmed: 25 1 2020
medline: 1 6 2021
entrez: 25 1 2020
Statut: ppublish

Résumé

Unfavorable histology on procurement biopsies is the most common reason for deceased donor kidney discard. We sought to assess the reproducibility of procurement biopsy findings. We compiled a continuous cohort of deceased donor kidneys transplanted at our institution from 1/1/2006 to 12/31/2016 that had at least one procurement biopsy performed, and excluded cases with missing biopsy reports and those used in multiorgan transplants. Suboptimal histology was defined as the presence of advanced sclerosis in greater than or equal to one biopsy compartment (glomeruli, tubules/interstitium, vessels). We calculated Of the 1011 kidneys included in our cohort, 606 (60%) had multiple procurement biopsies; 98% had first biopsy performed at another organ procurement organization and their second biopsy performed locally. Categorical agreement was highest for vascular disease ( Deceased donor kidneys that underwent multiple procurement biopsies often displayed substantial differences in histologic categorization in sequential biopsies, and there was no association between first biopsy findings and post-transplant outcomes.

Sections du résumé

BACKGROUND AND OBJECTIVES
Unfavorable histology on procurement biopsies is the most common reason for deceased donor kidney discard. We sought to assess the reproducibility of procurement biopsy findings.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS
We compiled a continuous cohort of deceased donor kidneys transplanted at our institution from 1/1/2006 to 12/31/2016 that had at least one procurement biopsy performed, and excluded cases with missing biopsy reports and those used in multiorgan transplants. Suboptimal histology was defined as the presence of advanced sclerosis in greater than or equal to one biopsy compartment (glomeruli, tubules/interstitium, vessels). We calculated
RESULTS
Of the 1011 kidneys included in our cohort, 606 (60%) had multiple procurement biopsies; 98% had first biopsy performed at another organ procurement organization and their second biopsy performed locally. Categorical agreement was highest for vascular disease (
CONCLUSIONS
Deceased donor kidneys that underwent multiple procurement biopsies often displayed substantial differences in histologic categorization in sequential biopsies, and there was no association between first biopsy findings and post-transplant outcomes.

Identifiants

pubmed: 31974289
pii: 01277230-202002000-00015
doi: 10.2215/CJN.09170819
pmc: PMC7015101
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-264

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001874
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002539
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK116066
Pays : United States

Informations de copyright

Copyright © 2020 by the American Society of Nephrology.

Références

Stewart DE, Garcia VC, Rosendale JD, Klassen DK, Carrico BJ: Diagnosing the decades-long rise in the deceased donor kidney discard rate in the United States. Transplantation 101: 575–587, 2017 27764031
Mohan S, Foley K, Chiles MC, Dube GK, Patzer RE, Pastan SO, Crew RJ, Cohen DJ, Ratner LE: The weekend effect alters the procurement and discard rates of deceased donor kidneys in the United States. Kidney Int 90: 157–163, 2016 27182001
Mohan S, Chiles MC, Patzer RE, Pastan SO, Husain SA, Carpenter DJ, Dube GK, Crew RJ, Ratner LE, Cohen DJ: Factors leading to the discard of deceased donor kidneys in the United States. Kidney Int 94: 187–198, 2018 29735310
Oniscu GC, Brown H, Forsythe JL: Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 16: 1859–1865, 2005 15857921
Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725–1730, 1999 10580071
Gross CR, Limwattananon C, Matthees B, Zehrer JL, Savik K: Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 70: 1736–1746, 2000 11152106
Marrero WJ, Naik AS, Friedewald JJ, Xu Y, Hutton DW, Lavieri MS, Parikh ND: Predictors of deceased donor kidney discard in the United States. Transplantation 101: 1690–1697, 2017 27163541
Husain SA, Chiles MC, Lee S, Pastan SO, Patzer RE, Tanriover B, Ratner LE, Mohan S: Characteristics and performance of unilateral kidney transplants from deceased donors. Clin J Am Soc Nephrol 13: 118–127, 2018 29217537
Bodzin AS, Leiby BE, Ramirez CB, Frank AM, Doria C: Expanded criteria donor kidneys where the paired kidney is discarded owing to biopsy results: A concept that needs revision. Exp Clin Transplant 12: 499–505, 2014 25489800
Kasiske BL, Stewart DE, Bista BR, Salkowski N, Snyder JJ, Israni AK, Crary GS, Rosendale JD, Matas AJ, Delmonico FL: The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. Clin J Am Soc Nephrol 9: 562–571, 2014 24558053
Sung RS, Christensen LL, Leichtman AB, Greenstein SM, Distant DA, Wynn JJ, Stegall MD, Delmonico FL, Port FK: Determinants of discard of expanded criteria donor kidneys: Impact of biopsy and machine perfusion. Am J Transplant 8: 783–792, 2008 18294347
Carpenter D, Husain SA, Brennan C, Batal I, Hall IE, Santoriello D, Rosen R, Crew RJ, Campenot E, Dube GK, Radhakrishnan J, Stokes MB, Sandoval PR, D’Agati V, Cohen DJ, Ratner LE, Markowitz G, Mohan S: Procurement biopsies in the evaluation of deceased donor kidneys. Clin J Am Soc Nephrol 13: 1876–1885, 2018 30361336
Mohan S, Campenot E, Chiles MC, Santoriello D, Bland E, Crew RJ, Rosenstiel P, Dube G, Batal I, Radhakrishnan J, Sandoval PR, Guarrera J, Stokes MB, D’Agati V, Cohen DJ, Ratner LE, Markowitz G: Association between reperfusion renal allograft biopsy findings and transplant outcomes. J Am Soc Nephrol 28: 3109–3117, 2017 28684646
Azancot MA, Moreso F, Salcedo M, Cantarell C, Perello M, Torres IB, Montero A, Trilla E, Sellarés J, Morote J, Seron D: The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors. Kidney Int 85: 1161–1168, 2014 24284518
Haas M, Segev DL, Racusen LC, Bagnasco SM, Melancon JK, Tan M, Kraus ES, Rabb H, Ugarte RM, Burdick JF, Montgomery RA: Arteriosclerosis in kidneys from healthy live donors: Comparison of wedge and needle core perioperative biopsies. Arch Pathol Lab Med 132: 37–42, 2008 18181671
Muruve NA, Steinbecker KM, Luger AM: Are wedge biopsies of cadaveric kidneys obtained at procurement reliable? Transplantation 69: 2384–2388, 2000 10868645
Pokorná E, Vítko S, Chadimová M, Schück O, Ekberg H: Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 69: 36–43, 2000 10653377
Organ Procurement and Transplantation Network: Guide to Calculating and Interpreting the Kidney Donor Profle Index (KDPI). Available at: https://optn.transplant.hrsa.gov/media/1512/guide_to_calculating_interpreting_kdpi.pdf . Accessed December 4, 2018
Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Castro S, Robinson A, Wainright JL, Snyder JJ, Kasiske BL, Israni AK: OPTN/SRTR 2017 annual data report: Kidney. Am J Transplant 19[Suppl 2]: 19–123, 2019 30811893
Bajwa M, Cho YW, Pham PT, Shah T, Danovitch G, Wilkinson A, Bunnapradist S: Donor biopsy and kidney transplant outcomes: An analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 84: 1399–1405, 2007 18091515
Cockfield SM, Moore RB, Todd G, Solez K, Gourishankar S: The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation. Transplantation 89: 559–566, 2010 20110855
De Vusser K, Lerut E, Kuypers D, Vanrenterghem Y, Jochmans I, Monbaliu D, Pirenne J, Naesens M: The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol 24: 1913–1923, 2013 23949799
Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO: Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 60: 334–339, 1995 7652761
Lopes JA, Moreso F, Riera L, Carrera M, Ibernon M, Fulladosa X, Grinyó JM, Serón D: Evaluation of pre-implantation kidney biopsies: Comparison of Banff criteria to a morphometric approach. Kidney Int 67: 1595–1600, 2005 15780116
Navarro MD, López-Andréu M, Rodríguez-Benot A, Ortega-Salas R, Morales ML, López-Rubio F, García PA: Significance of preimplantation analysis of kidney biopsies from expanded criteria donors in long-term outcome. Transplantation 91: 432–439, 2011 21157404
Snoeijs MG, Buurman WA, Christiaans MH, van Hooff JP, Goldschmeding R, van Suylen RJ, Peutz-Kootstra CJ, van Heurn LW: Histological assessment of preimplantation biopsies may improve selection of kidneys from old donors after cardiac death. Am J Transplant 8: 1844–1851, 2008 18786228
Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD: The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152: 561–567, 2010 20439574
Hopfer H, Kemény É: Assessment of donor biopsies. Curr Opin Organ Transplant 18: 306–312, 2013 23492644

Auteurs

S Ali Husain (SA)

Division of Nephrology, Department of Medicine and.
The Columbia University Renal Epidemiology Group, New York, New York.

Kristen L King (KL)

Division of Nephrology, Department of Medicine and.
The Columbia University Renal Epidemiology Group, New York, New York.

Ibrahim Batal (I)

Departments of Pathology and.

Geoffrey K Dube (GK)

Division of Nephrology, Department of Medicine and.

Isaac E Hall (IE)

Division of Nephrology and Hypertension, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah.

Corey Brennan (C)

The Columbia University Renal Epidemiology Group, New York, New York.
Kidney and Pancreas Transplant Program, New York Presbyterian Hospital, New York, New York.

M Barry Stokes (MB)

Departments of Pathology and.

R John Crew (RJ)

Division of Nephrology, Department of Medicine and.

Dustin Carpenter (D)

Surgery, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York.

Hector Alvarado Verduzco (H)

Division of Nephrology, Department of Medicine and.

Raphael Rosen (R)

Division of Nephrology, Department of Medicine and.

Shana Coley (S)

Departments of Pathology and.

Eric Campenot (E)

Departments of Pathology and.

Dominick Santoriello (D)

Departments of Pathology and.

Adler Perotte (A)

Department of Biomedical Informatics, Columbia University, New York, New York; and.

Karthik Natarajan (K)

Department of Biomedical Informatics, Columbia University, New York, New York; and.

Vivette D D'Agati (VD)

Departments of Pathology and.

David J Cohen (DJ)

Division of Nephrology, Department of Medicine and.

Lloyd E Ratner (LE)

Surgery, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York.

Glen Markowitz (G)

Departments of Pathology and.

Sumit Mohan (S)

Division of Nephrology, Department of Medicine and.
The Columbia University Renal Epidemiology Group, New York, New York.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH